Cutting edge:: The Toll pathway is required for resistance to Gram-positive bacterial infections in Drosophila

被引:171
|
作者
Rutschmann, S [1 ]
Kilinc, A [1 ]
Ferrandon, D [1 ]
机构
[1] CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 04期
关键词
D O I
10.4049/jimmunol.168.4.1542
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Drosophila, the response against various microorganisms involves different recognition and signaling pathways, as well as distinct antimicrobial effectors. On the one hand, the immune deficiency pathway regulates the expression of antimicrobial peptides that are active against Gram-negative bacteria. On the other hand, the Toll pathway is involved in the defense against filamentous fungi and controls the expression of antifungal peptide genes. The gene coding for the only known peptide with high activity against Gram-positive bacteria, Defensin, is regulated by both pathways. So far, survival experiments to Gram-positive bacteria have been performed with Micrococcus luteus and have failed to reveal the involvement of one or the other pathway in host defense against such infections. In this study, we report that the Toll pathway, but not that of immune deficiency, is required for resistance to other Gram-positive bacteria and that this response does not involve Defensin.
引用
收藏
页码:1542 / 1546
页数:5
相关论文
共 50 条
  • [1] Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections
    Servane Tauszig-Delamasure
    Hana Bilak
    Maria Capovilla
    Jules A. Hoffmann
    Jean-Luc Imler
    [J]. Nature Immunology, 2002, 3 : 91 - 97
  • [2] Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections
    Tauszig-Delamasure, S
    Bilak, H
    Capovilla, M
    Hoffmann, JA
    Imler, JL
    [J]. NATURE IMMUNOLOGY, 2002, 3 (01) : 91 - 97
  • [3] Emerging gram-positive bacterial infections
    Elsayed, S
    Laupland, KB
    [J]. CLINICS IN LABORATORY MEDICINE, 2004, 24 (03) : 587 - +
  • [4] The Toll pathway underlies host sexual dimorphism in resistance to both Gram-negative and Gram-positive bacteria in mated Drosophila
    Duneau, David F.
    Kondolf, Hannah C.
    Im, Joo Hyun
    Ortiz, Gerardo A.
    Chow, Christopher
    Fox, Michael A.
    Eugenio, Ana T.
    Revah, J.
    Buchon, Nicolas
    Lazzaro, Brian P.
    [J]. BMC BIOLOGY, 2017, 15
  • [5] The Toll pathway underlies host sexual dimorphism in resistance to both Gram-negative and Gram-positive bacteria in mated Drosophila
    David F. Duneau
    Hannah C. Kondolf
    Joo Hyun Im
    Gerardo A. Ortiz
    Christopher Chow
    Michael A. Fox
    Ana T. Eugénio
    J. Revah
    Nicolas Buchon
    Brian P. Lazzaro
    [J]. BMC Biology, 15
  • [6] THERAPY OF GRAM-POSITIVE BACTERIAL-INFECTIONS
    PAPICH, MG
    [J]. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1988, 18 (06) : 1267 - 1285
  • [7] Novel antibiotics for the treatment of gram-positive bacterial infections
    Brands, M
    Endermann, R
    Gahlmann, R
    Krüger, J
    Raddatz, S
    Stoltefuss, J
    Belov, VN
    Nizamov, S
    Sokolov, VV
    de Meijere, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) : 4246 - 4253
  • [8] Strategies for the successful treatment of gram-positive bacterial infections
    Remington, JS
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 : S150 - S151
  • [9] Management of gram-positive bacterial infections in patients with cancer
    Kosmidis, Christos I.
    Chandrasekar, Pranatharthi H.
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 8 - 18
  • [10] Surveillance of gram-positive cocci infections and drug resistance
    Li, G.
    Hou, S.
    Li, Y.
    Liu, S.
    Teng, D.
    Hou, D.
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (04) : 90 - 93